# Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

> **NCT00248066** · PHASE2 · COMPLETED · sponsor: **Sarepta Therapeutics, Inc.** · enrollment: 50 (—)

## Conditions studied

- Coronary Artery Disease
- Coronary Restenosis

## Interventions

- **DRUG:** RESTEN-MP

## Key facts

- **NCT ID:** NCT00248066
- **Lead sponsor:** Sarepta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2007-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00248066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00248066, "Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00248066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*